The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism

Discrimination and Calibration of Clinical Prediction Models

(2017) Ana Carolina Alba et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

External validation of the VTE-BLEED score for predicting major bleeding in stable anticoagulated patients with venous thromboembolism

(2017) Stefano Barco et al.   THROMBOSIS AND HAEMOSTASIS

Bleeding risk in patients with unprovoked venous thromboembolism: A critical appraisal of clinical prediction scores

(2017) Nick van Es et al.   THROMBOSIS RESEARCH

Antithrombotic Therapy for VTE Disease

(2016) Clive Kearon et al.   CHEST

Brave real world

(2016) F. R. Rosendaal et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH

(2016) C. Kearon et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

(2016) Ziad Hijazi et al.   LANCET

The SAME-TT2R2 score predicts the quality of anticoagulation control in patients with acute VTE

(2016) Emilia Antonucci et al.   THROMBOSIS AND HAEMOSTASIS

Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH

(2015) S. Kaatz et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation

(2015) Emilia Antonucci et al.   PLoS One

D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study

(2014) G. Palareti et al.   BLOOD

Comparison of four scores to predict major bleeding in patients receiving anticoagulation for venous thromboembolism: findings from the RIETE registry

(2014) Chiara Piovella et al.   Internal and Emergency Medicine

Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism

(2014) Marta Bellesini et al.   THROMBOSIS AND HAEMOSTASIS

Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism

(2013) Sam Schulman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban for Extended Treatment of Venous Thromboembolism

(2012) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry

(2008) Nuria Ruíz-Giménez et al.   THROMBOSIS AND HAEMOSTASIS